Article
Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.
Japanese journal of clinical oncology - 1 Jul 2021
Takeyasu Yuki, Yoshida Tatsuya, Motoi Noriko, Teishikata Takashi, Tanaka Midori, Matsumoto Yuji, Shinno Yuki, Okuma Yusuke, Goto Yasushi, Horinouchi Hidehito, Kakishima Hiroki, Tsuchida Takaaki, Yamamoto Noboru, Ohe Yuichiro, Yatabe Yasushi
Abstract excerpt
BACKGROUND: The Oncomine™ Dx Target Test based on next-generation sequencing has been approved for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. METHODS: We assessed the tissue sample factors that affect the success rate of Oncomine™ Dx Target Test companion diagnostics and the feasibility of using biopsy specimens for Oncomine™ Dx Target Test companion diagnostics in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.